Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma

International Journal of Oncology

Volumn 30, Issue 1, 2007, Pages 97-103

  Shimada, Hideaki ^a   Kuboshima, Mari ^a   Shiratori, Tooru ^a   Nabeya, Yoshihiro ^a   Takeuchi, Atsushi ^a   Takagi, Hiroaki ^b   Nomura, Fumio ^a   Takiguchi, Masaki ^a   Ochiai, Takenori ^a   Hiwasa, Takaki ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Protein Express Co Ltd   (Japan)

Author keywords

Esophageal squamous cell carcinoma; Myomegalin; SEREX; Tumor marker

Indexed keywords

AUTOANTIBODY; COMPLEMENTARY DNA; MICROTUBULE ASSOCIATED PROTEIN; PDE4DIP PROTEIN, RAT; PRIMER DNA; TUMOR MARKER;

AGED; ARTICLE; BLOOD; ESOPHAGUS TUMOR; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL; WESTERN BLOTTING;

AGED; AUTOANTIBODIES; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; DNA, COMPLEMENTARY; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 39049178742     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.30.1.97     Document Type: Article

References (31)

1. The Japanese Society for Esophageal Diseases: Comprehensive registry of esophageal cancer in Japan, 1999. Esophagus 2: 43-69, 2005.
2. Daly JM, Karnell LH and Menck HR: National cancer data base report on esophageal carcinoma. Cancer 78: 1820-1828, 1996.
3. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Miyazawa Y, Shiratori T, Hayashi H, Gunji Y and Ochiai T: Prognostic significance of serum CYFRA21-1 in the patients with esophageal squamous cell carcinoma. J Am Coll Surg 196: 573-578, 2003. (Pubitemid 36428262)
4. Shimada H, Nabeya Y, Okazumi S, Matsubara H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H and Ochiai T: Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma. Surgery 133: 486-494, 2003. (Pubitemid 36638220)
5. Shimada H, Takeda A, Arima M, Okazumi S, Matsubara H, Nabeya Y, Funami Y, Hayashi H, Gunji Y, Suzuki T, Kobayashi S and Ochiai T: Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma. Cancer 89: 1677-1683, 2000.
6. Shimada H, Ochiai T and Nomura F: Titration of serum p53 antibodies in 1,085 patients with various types of malignant tumors: a multiinstitutional analysis by the Japan p53 antibody research group. Cancer 97: 682-689, 2003.
7. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I and Pfreundschuh M: Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92: 11810-11813, 1995.
8. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M and Old LJ: A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94: 1914-1918, 1997.
9. Nakashima K, Shimada H, Ochiai T, Kuboshima M, Kuroiwa N, Okazaumi S, Matsubara H, Nomura F, Takiguchi M and Hiwasa T: Serological identification of TROP2 by recombinant cDNA expression cloning using sera of patients with esophageal squamous cell carcinoma. Int J Cancer 112: 1029-1035, 2004.
10. Shimada H, Nakashima K, Ochiai T, Nabeya Y, Takiguchi M, Nomura F and Hiwasa T: Serological identification of tumor antigens of esophageal squamous cell carcinoma. Int J Oncol 26: 77-86, 2005.
11. Kuboshima M, Shimada H, Liu TL, Nakashima K, Nomura F, Takiguchi M, Hiwasa T and Ochiai T: Identification of a novel SEREX antigen, SLC2A1/GLUT1, in esophageal squamous cell carcinoma. Int J Oncol 28: 463-468, 2006.
12. Kuboshima M, Shimada H, Liu TL, Nomura F, Takiguchi M, Hiwasa T and Ochiai T: Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma. Cancer Sci 97: 380-386, 2006.
13. Hiwasa T, Shimada H, Ochiai T and Takiguchi M: Serological identification of antigens by recombinant cDNA expression cloning (SEREX) using antibodies from patients with esophageal squamous cell carcinoma. In: Moleculomics and Thereafter. Hiwasa T (ed). Research Signpost, Kerala, pp99-117, 2006.
14. Van der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES, Chapiro J, van den Eynde BJ, Brasseur F and Boon T: Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 188: 51-64, 2002. (Pubitemid 35398865)
15. Rosenberg SA: Progress in human tumour immunology and immunotherapy. Nature 411: 380-384, 2001.
16. Preuss KD, Zwick C, Bormann C, Neumann F and Pfreundschuh M: Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol Rev 188: 43-50, 2002. (Pubitemid 35398864)
17. Shimada H, Shimizu T, Ochiai T, Liu TL, Sashiyama H, Nakamura A, Matsubara H, Gunji Y, Kobayashi S, Tagawa M, Sakiyama S and Hiwasa T: Preclinical study of adenovirus p53 gene therapy for esopahgeal cancer. Surg Today 31: 597-604, 2001.
18. Nishihira T, Hashimoto Y, Katayama M, Mori S and Kuroki T: Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 119: 441-449, 1993.
19. Oka M, Hirose K, Iizuka N, Aoyagi K, Yamamoto K, Abe T, Hazama S and Suzuki T: Cytokine mRNA expression patterns in human esophageal cancer cell lines. J Interferon Cytokine Res 15: 1005-1009, 1995.
20. Sashiyama H, Shino Y, Kawamata Y, Tomita Y, Ogawa N, Shimada H, Kobayashi S, Asano T, Ochiai T and Shirasawa H: Immortalization of human esophageal keratinocytes by E6 and E7 of human papillomavirus type 16. Int J Oncol 19: 97-103, 2001.
21. Sobin LH and Wittekind CH (eds): UICC TNM Classification of malignant tumors. 6th edition. John Wiley & Sons, Inc., New York, 2002.
22. Nabeya Y, Ochiai T, Matsubara H, Okazumi S, Shiratori T, Shuto K, Aoki T, Miyazaki S, Gunji Y, Uno T, Ito H and Shimada H: Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis. Dis Esophagus 18: 388-397, 2005.
23. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
24. Hsu SM, Raine L and Fanger AH: A comparative study of the peroxidase method and an avidine-biotin complex method for studying polypeptide hormones with radioimmunoassay antibody. Am J Clin Pathol 75: 734-738, 1981. (Pubitemid 11117256)
25. Verde I, Pahlke G, Salanova M, Zhang G, Wang S, Coletti D, Onuffer J, Jin SLC and Conti M: Myomegalin is a novel protein of the Golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase. J Biol Chem 276: 11189-11198, 2001.
26. Wilkinson K, Velloso ER, Lopes LF, Lee C, Aster JC, Shipp MA and Aguiar RC: Cloning of the t(1;5)(q23;q33) in a myeloproliferative disorder associated with eosinophilia: involvement of PDGFRB and response to imatinib. Blood 102: 4187-4190, 2003.
27. Soejima H, Kawamoto S, Akai J, Miyoshi O, Arai Y, Morohka T, Matsuo S, Niikawa N, Kimura A, Okubo K and Mukai T: Isolation of novel heart-specific genes using the BodyMap database. Genomics 74: 115-120, 2001.
28. Nakao M, Shichijo S, Imaizumi T, Inoue Y, Matsunaga K, Yamada A, Kikuchi M, Tsuda N, Ohta K, Takamori S, Yamana H, Fujita H and Itoh K: Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL. J Immunol 164: 2565-2574, 2000. (Pubitemid 30115487)
29. Diesinger I, Bauer C, Brass N, Schaefers HJ and Comtesse N: Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma. Int J Cancer 102: 372-378, 2002.
30. Jäger E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old L and Knuth A: Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 187: 265-270, 1998.
31. Toh U, Sudo T, Kido K, Matono S, Sasahara H, Mine T, Tanaka T, Sueyoshi S, Fujita H, Shirouzu K and Yamana H: Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancer. Int J Clin Oncol 7: 372-375, 2002. (Pubitemid 36077322)